News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
506,892 Results
Type
Article (38703)
Company Profile (252)
Press Release (467929)
Multimedia
Podcasts (105)
Webinars (11)
Section
Business (137345)
Career Advice (1012)
Deals (24662)
Drug Delivery (98)
Drug Development (68310)
Employer Resources (97)
FDA (13354)
Job Trends (10466)
News (244119)
Policy (21985)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2053)
Academic (1)
Accelerated approval (34)
Adcomms (28)
Allergies (103)
Alliances (35777)
ALS (162)
Alzheimer's disease (1477)
Antibody-drug conjugate (ADC) (319)
Approvals (13553)
Artificial intelligence (474)
Autoimmune disease (159)
Automation (34)
Bankruptcy (187)
Best Places to Work (8854)
BIOSECURE Act (16)
Biosimilars (159)
Biotechnology (190)
Bladder cancer (156)
Brain cancer (60)
Breast cancer (612)
Cancer (4710)
Cardiovascular disease (391)
Career advice (865)
Career pathing (17)
CAR-T (314)
CDC (22)
Celiac Disease (2)
Cell therapy (841)
Cervical cancer (29)
Clinical research (59041)
Collaboration (1649)
Company closure (2)
Compensation (786)
Complete response letters (63)
COVID-19 (2087)
CRISPR (100)
C-suite (752)
Cystic fibrosis (150)
Data (5933)
Denatured (17)
Depression (131)
Diabetes (445)
Diagnostics (5218)
Digital health (34)
Diversity (5)
Diversity, equity & inclusion (28)
Drug discovery (252)
Drug pricing (133)
Drug shortages (26)
Duchenne muscular dystrophy (242)
Earnings (59823)
Editorial (48)
Employer branding (15)
Employer resources (89)
Events (75668)
Executive appointments (811)
FDA (16164)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (11)
Frontotemporal dementia (22)
Funding (1342)
Gene editing (220)
Generative AI (48)
Gene therapy (686)
GLP-1 (850)
Government (2982)
Grass and pollen (5)
Guidances (363)
Healthcare (13952)
HIV (52)
Huntington's disease (48)
IgA nephropathy (85)
Immunology and inflammation (232)
Immuno-oncology (59)
Indications (104)
Infectious disease (2303)
Inflammatory bowel disease (180)
Inflation Reduction Act (11)
Influenza (92)
Intellectual property (220)
Interviews (167)
IPO (12576)
IRA (29)
Job creations (2014)
Job search strategy (728)
JPM (58)
Kidney cancer (16)
Labor market (45)
Layoffs (456)
Leadership (23)
Legal (4670)
Liver cancer (81)
Longevity (14)
Lung cancer (636)
Lymphoma (377)
Machine learning (38)
Management (28)
Manufacturing (692)
MASH (156)
Medical device (8780)
Medtech (8814)
Mergers & acquisitions (13055)
Metabolic disorders (1169)
Multiple sclerosis (153)
NASH (17)
Neurodegenerative disease (320)
Neuropsychiatric disorders (91)
Neuroscience (2674)
Neurotech (1)
NextGen: Class of 2026 (4233)
Non-profit (2961)
Now hiring (30)
Obesity (557)
Opinion (238)
Ovarian cancer (156)
Pain (183)
Pancreatic cancer (212)
Parkinson's disease (275)
Partnered (27)
Patents (421)
Patient recruitment (478)
Peanut (46)
People (40127)
Pharmaceutical (46)
Pharmacy benefit managers (21)
Phase 1 (18691)
Phase 2 (26018)
Phase 3 (19689)
Pipeline (4975)
Policy (199)
Postmarket research (1989)
Preclinical (7656)
Press Release (71)
Prostate cancer (231)
Psychedelics (55)
Radiopharmaceuticals (276)
Rare diseases (903)
Real estate (3291)
Recruiting (38)
Regulatory (18257)
Reports (30)
Research institute (2111)
Resumes & cover letters (170)
Rett syndrome (27)
RNA editing (20)
RSV (61)
Schizophrenia (143)
Series A (236)
Series B (182)
Service/supplier (6)
Sickle cell disease (104)
Special edition (17)
Spinal muscular atrophy (171)
Sponsored (37)
Startups (2683)
State (1)
Stomach cancer (17)
Supply chain (79)
Tariffs (55)
The Weekly (87)
Vaccines (779)
Venture capital (78)
Weight loss (354)
Women's health (62)
Worklife (7)
Date
Today (22)
Last 7 days (462)
Last 30 days (1745)
Last 365 days (26375)
2026 (3040)
2025 (26643)
2024 (30188)
2023 (33559)
2022 (42324)
2021 (45260)
2020 (41211)
2019 (32410)
2018 (24604)
2017 (24731)
2016 (22783)
2015 (26387)
2014 (18976)
2013 (22442)
2012 (15682)
2011 (16112)
2010 (14669)
Location
Africa (525)
Alabama (59)
Alaska (5)
Arizona (174)
Arkansas (7)
Asia (31024)
Australia (5462)
California (9744)
Canada (2708)
China (1054)
Colorado (359)
Connecticut (428)
Delaware (281)
Europe (72472)
Florida (1461)
Georgia (285)
Hawaii (3)
Idaho (43)
Illinois (658)
India (64)
Indiana (424)
Iowa (18)
Japan (391)
Kansas (99)
Kentucky (36)
Louisiana (22)
Maine (49)
Maryland (1144)
Massachusetts (7324)
Michigan (262)
Minnesota (477)
Mississippi (5)
Missouri (121)
Montana (21)
Nebraska (13)
Nevada (98)
New Hampshire (57)
New Jersey (2720)
New Mexico (25)
New York (2559)
North Carolina (1271)
North Dakota (9)
Northern California (4834)
Ohio (266)
Oklahoma (10)
Oregon (29)
Pennsylvania (1868)
Puerto Rico (17)
Rhode Island (33)
South America (686)
South Carolina (32)
South Dakota (1)
Southern California (3744)
Tennessee (102)
Texas (1456)
United States (34287)
Utah (293)
Vermont (1)
Virginia (214)
Washington D.C. (60)
Washington State (815)
West Virginia (4)
Wisconsin (98)
Wyoming (2)
506,892 Results for "taysha gene therapies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Taysha Gene Therapies Announces Progress Across TSHA-102 Pivotal Gene Therapy Program in Rett Syndrome
January 6, 2026
·
7 min read
Press Releases
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - February 6, 2026
February 8, 2026
·
1 min read
Press Releases
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - December 5, 2025
December 8, 2025
·
2 min read
Press Releases
Taysha Gene Therapies Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 5, 2025
·
14 min read
Press Releases
Taysha Gene Therapies to Release Third Quarter 2025 Financial Results and Host Conference Call and Webcast on November 4
October 29, 2025
·
1 min read
Gene therapy
In Vivo Is Having a Moment as Cell and Gene Therapy Sector Gathers in San Diego
A recurring theme Tuesday morning at Phacilitate’s Advanced Therapies Week was the quickly emerging potential of in vivo approaches to cell and gene therapy—a trend also reflected in recent investments by Eli Lilly and Regeneron.
February 11, 2026
·
4 min read
·
Heather McKenzie
Press Releases
Taysha Gene Therapies Announces FDA Breakthrough Therapy Designation and Provides Positive Regulatory Update on TSHA-102 in Rett Syndrome
October 3, 2025
·
9 min read
Press Releases
Taysha Gene Therapies Regains Full Rights to Lead TSHA-102 Program in Clinical Evaluation for the Treatment of Rett Syndrome
October 17, 2025
·
8 min read
Complete response letters
REGENXBIO’s Hunter Syndrome Gene Therapy Fails To Win FDA Nod
The FDA recommended that REGENXBIO run a new study, treat more patients and include a placebo arm to support a resubmission for the gene therapy RGX-121.
February 10, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - October 3, 2025
October 5, 2025
·
2 min read
1 of 50,690
Next
